Lanean...
The effect of thymosin α1 on mortality of critical COVID-19 patients: A multicenter retrospective study
BACKGROUND: Thymosin α1 therapy was commonly used in patients with coronavirus disease 2019 (COVID-19), while its impact on outcomes and which patients could benefit from thymosin α1 therapy were uncertain. STUDY DESIGN AND METHODS: Patients with COVID-19 from 19 designated hospitals between January...
Gorde:
| Argitaratua izan da: | Int Immunopharmacol |
|---|---|
| Egile Nagusiak: | , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Elsevier B.V.
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7604217/ https://ncbi.nlm.nih.gov/pubmed/33208294 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.intimp.2020.107143 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|